Adil Rasheed
Impact in
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases
-
- Nanoparticle-Based Drug Delivery
Papers in
- Immunology 13
- Atherosclerosis and Cardiovascular Diseases 12
- Immune cells in cancer 1
- Surgery 7
- Cholesterol and Lipid Metabolism 6
- Co-authors
- Katey J. Rayner (11 shared papers)Carolyn L. Cummins (6 shared papers)Michèle Geoffrion (7 shared papers)Hailey Wyatt (4 shared papers)My-Anh Nguyen (6 shared papers)Anne‐Claire Duchez (3 shared papers)Suresh Gadde (2 shared papers)Marceline Côté (1 shared paper)
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (3 papers)Journal of the American Heart Association (1 paper)Canadian Journal of Cardiology (1 paper)ACS Nano (1 paper)Endocrine Reviews (1 paper)
- Partner nations
- CanadaUnited StatesTürkiye
In The Last Decade
Adil Rasheed
22 papers receiving 774 citations
Peers
Comparison fields: 5 of 74
- Immunology 212
- Biomaterials 67
- Cancer Research 63
- Molecular Biology 236
- Nephrology 36
Countries citing papers authored by Adil Rasheed
This map shows the geographic impact of Adil Rasheed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adil Rasheed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adil Rasheed more than expected).
Fields of papers citing papers by Adil Rasheed
This network shows the impact of papers produced by Adil Rasheed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adil Rasheed. The network helps show where Adil Rasheed may publish in the future.
Co-authors
The 25 scholars most cited alongside Adil Rasheed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 166 | |
| 2 | 2019 | 137 | |
| 3 | 2015 | 65 | |
| 4 | 2012 | 64 | |
| 5 | 2020 | 58 | |
| 6 | 2021 | 56 | |
| 7 | 2022 | 51 | |
| 8 | 2020 | 47 | |
| 9 | 2013 | 42 | |
| 10 | 2018 | 36 | |
| 11 | 2025 | 15 | |
| 12 | 2020 | 9 | |
| 13 | 2018 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 6 | |
| 16 | 2026 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Adil Rasheed
Adil Rasheed is a scholar working on Immunology, Surgery, Epidemiology, Nephrology and Ophthalmology, having authored 23 papers that have together received 783 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (12 papers), Cholesterol and Lipid Metabolism (6 papers), Autophagy in Disease and Therapy (2 papers), RNA Interference and Gene Delivery (1 paper), Immune cells in cancer (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Health and Medical Research Impacts (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Immunology (212 citations), Biomaterials (67 citations), Cancer Research (63 citations), Molecular Biology (236 citations) and Nephrology (36 citations). Adil Rasheed has collaborated with scholars based in Canada, United States and Türkiye. Frequent co-authors include Katey J. Rayner, Carolyn L. Cummins, Michèle Geoffrion, Hailey Wyatt, My-Anh Nguyen, Anne‐Claire Duchez, Suresh Gadde, Marceline Côté, Eliya Farah and Mireille I. Ouimet. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of the American Heart Association, Canadian Journal of Cardiology, ACS Nano and Endocrine Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.